Sign in to view content

New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus

Bobeck S Modjtahedi, MD

Video
Published 2022

Related

Prospective Evaluation of Pain and Inflammation Following Injection of Aflibercept or Ranibizumab in Patients With Diabetic Macular Edema: SOLAR Study
Nikolas JS London, MD, FACS, FASRS
Annual Meeting Talks
2018
Intravitreal Anti-VEGF Therapy in Maintaining Long-term Driving Vision in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Parisa Emami Naeini, MD, MPH, FASRS
Annual Meeting Talks
2021
Outcomes of the HORNBILL Study: A Phase I/IIa Trial Investigating BI 764524 in Patients With Diabetic Macular Ischemia
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Updates from the Field
2024

Category: Diabetic Retinopathy

See more